Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
76.4M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
193M
-
Shares change
-
+6.56M
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
+$56.9M
-
Put/Call ratio
-
0.81
-
Number of buys
-
76
-
Number of sells
-
-81
-
Price
-
$7.18
Significant Holders of Endo International plc - Common Stock, par value $0.001 per share (ENDPQ) as of Q4 2020
220 filings reported holding ENDPQ - Endo International plc - Common Stock, par value $0.001 per share as of Q4 2020.
Endo International plc - Common Stock, par value $0.001 per share (ENDPQ) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 193M shares
.
Largest 10 shareholders include BlackRock Inc. (36.7M shares), VANGUARD GROUP INC (25.3M shares), RENAISSANCE TECHNOLOGIES LLC (19.6M shares), PAULSON & CO. INC. (18.3M shares), Contrarius Investment Management Ltd (11M shares), STATE STREET CORP (8.12M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (7.49M shares), MORGAN STANLEY (6.11M shares), JPMORGAN CHASE & CO (4.89M shares), and NORGES BANK (4M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.